India’s biggest pharma company, Ranbaxy Laboratories Ltd has announced that it has rec

Glenmark Pharmaceuticals Ltd has announced that its Swiss unit, Glenmark Pharmaceuticals SA, has received USD 15 Million as milestone fees from Forest Laboratories, its North American partner, for an anti-asthma drug Oglemilast molecule.

Both companies are working together to initiate additional studies for further longer term development of oglemilast, including a Phase II study in Asthma.

Drug Major Sun Pharmaceuticals has announced the commercial launch of generic Pantoprazole Sodium Delayed Release (DR) Tablets, 40 mg in the market. The drug is used for treating oesophagus ailments.

Sun Pharmaceuticals has launched the drug after the commercial launch by Teva Pharmaceutical Industries and Wyeth’s generic Pantoprazole Sodium tablets product.

This strength of Pantoprazole Sodium has annual sales of around 2.3 billion dollar in the US. The product is being sold by its marketing partner Caraco Pharmaceutical Laboratories.

The company had received a USFDA approval for these tablets in Sep 2007.